JP2004533481A5 - - Google Patents

Download PDF

Info

Publication number
JP2004533481A5
JP2004533481A5 JP2003510423A JP2003510423A JP2004533481A5 JP 2004533481 A5 JP2004533481 A5 JP 2004533481A5 JP 2003510423 A JP2003510423 A JP 2003510423A JP 2003510423 A JP2003510423 A JP 2003510423A JP 2004533481 A5 JP2004533481 A5 JP 2004533481A5
Authority
JP
Japan
Prior art keywords
protecting group
hydrogen
formula
compound
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003510423A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004533481A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/007308 external-priority patent/WO2003004455A2/en
Publication of JP2004533481A publication Critical patent/JP2004533481A/ja
Publication of JP2004533481A5 publication Critical patent/JP2004533481A5/ja
Pending legal-status Critical Current

Links

JP2003510423A 2001-07-06 2002-07-02 7−アミノsyn3,5−ジヒドロキシヘプタン酸誘導体の製造方法、それらの中間体及び中間体の製造方法 Pending JP2004533481A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01810670 2001-07-06
PCT/EP2002/007308 WO2003004455A2 (en) 2001-07-06 2002-07-02 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation

Publications (2)

Publication Number Publication Date
JP2004533481A JP2004533481A (ja) 2004-11-04
JP2004533481A5 true JP2004533481A5 (cg-RX-API-DMAC7.html) 2005-12-22

Family

ID=41546668

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003510423A Pending JP2004533481A (ja) 2001-07-06 2002-07-02 7−アミノsyn3,5−ジヒドロキシヘプタン酸誘導体の製造方法、それらの中間体及び中間体の製造方法

Country Status (15)

Country Link
US (2) US7317123B2 (cg-RX-API-DMAC7.html)
EP (1) EP1404642B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004533481A (cg-RX-API-DMAC7.html)
AT (1) ATE457972T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002328835A1 (cg-RX-API-DMAC7.html)
CA (1) CA2453211A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ2004158A3 (cg-RX-API-DMAC7.html)
DE (1) DE60235365D1 (cg-RX-API-DMAC7.html)
DK (1) DK1404642T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20040117A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0401006A2 (cg-RX-API-DMAC7.html)
IL (1) IL159718A0 (cg-RX-API-DMAC7.html)
PL (1) PL367774A1 (cg-RX-API-DMAC7.html)
SK (1) SK792004A3 (cg-RX-API-DMAC7.html)
WO (1) WO2003004455A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002057229A1 (en) 2001-01-19 2002-07-25 Biocon India Limited FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß,$G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN)
WO2003004450A1 (en) 2001-07-06 2003-01-16 Ciba Specialty Chemicals Holding Inc. Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof
US7361772B2 (en) 2001-08-16 2008-04-22 Biocon Limited Process for the production of atorvastatin calcium
ATE452871T1 (de) 2002-03-18 2010-01-15 Biocon Ltd Amorphe hmg-coa-reduktase-inhibitoren mit gewünschter teilchengrösse
US7179942B2 (en) 2002-07-05 2007-02-20 Bicon Limited Halo-substituted active methylene compounds
PT1631533E (pt) 2003-04-22 2009-06-04 Biocon Ltd Novo processo para a redução estereosselectiva de betacetoésteres
ES2317012T3 (es) 2003-06-18 2009-04-16 Teva Pharmaceutical Industries Limited Forma xiv cristali8na de fluvastatina sodica, sus procedimientos de preparacion, composiciones que la contienen y sus procedimientos de utilizacion.
US7368468B2 (en) 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them
WO2005026107A1 (en) 2003-09-18 2005-03-24 Biocon Limited Novel process for the preparation of tert-butyl 6-cyano-5-hydroxy-3-oxohexanoate
US7851624B2 (en) 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
WO2007022488A2 (en) 2005-08-16 2007-02-22 Teva Pharmaceutical Industries Ltd. Crystalline rosuvastatin intermediate
EP2778229A1 (de) 2013-03-11 2014-09-17 Sandoz Ag Verfahren zur enantioselektiven Herstellung von 3-Hydroxyglutarsäuremonoestern und deren Verwendung
CN103361386B (zh) * 2013-06-28 2015-04-15 苏州汉酶生物技术有限公司 一种罗素伐他汀中间体的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097045A (en) * 1989-02-01 1992-03-17 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
US5003080A (en) 1988-02-22 1991-03-26 Warner-Lambert Company Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
IT1226726B (it) * 1988-07-29 1991-02-05 Zambon Spa Composti attivi come inibitori della biosintesi del colesterolo.
JPH02115234A (ja) * 1988-10-26 1990-04-27 Tdk Corp 架橋ポリフッ化ビニリデンの製造方法
US4994602A (en) 1989-02-27 1991-02-19 Takasago International Corporation Process for preparing optically active 6-t-butyoxy-3,5-dihydroxyhexanoic esters
JPH0791223B2 (ja) * 1989-02-27 1995-10-04 高砂香料工業株式会社 光学活性6―t―ブトキシ―3,5―ジヒドロキシヘキサン酸エステルの製造法
IT1237792B (it) * 1989-12-21 1993-06-17 Zambon Spa Composti attivi come inibitori dell'enzima hmg-coa reduttasi
US5051502A (en) * 1990-06-06 1991-09-24 University Of Notre Dame Du Lac Rhodium catalyzed cyclization process for bicyclic β-lactams
US5248793A (en) * 1990-10-17 1993-09-28 Warner-Lambert Company Process for the synthesis of (4R-cis)-1,1-dimethylethyl 6-iodomethyl or 6-(phenyl-substituted)sulfonyloxymethyl-2,2-dimethyl-1,3-dioxane-4-acetate
US5155251A (en) 1991-10-11 1992-10-13 Warner-Lambert Company Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate
US5298627A (en) * 1993-03-03 1994-03-29 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
JP3652394B2 (ja) * 1995-01-27 2005-05-25 高砂香料工業株式会社 N−置換−7−アミノ−5−ヒドロキシ−3−オキソヘプタン酸誘導体およびその製造法
DK1054860T3 (da) 1997-12-19 2007-07-02 Pfizer Ireland Pharmaceuticals Proces for syntesen af 1,3-dioler
DE19920784A1 (de) 1999-05-05 2000-11-09 Bayer Ag Stilbenaufheller

Similar Documents

Publication Publication Date Title
US7692034B2 (en) Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives
US8026383B2 (en) Process for the preparation of intermediates useful in the synthesis of statin derivatives
US7504532B2 (en) Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
AU2002354701A1 (en) Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof
JP2004533481A5 (cg-RX-API-DMAC7.html)
US20050014954A1 (en) Pyrrole synthesis